CXCL16 suppresses liver metastasis of colorectal cancer by promoting TNF-α-induced apoptosis by tumor-associated macrophages

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Kee, Ji Ye ^a   Ito, Aya ^a   Hojo, Shozo ^a   Hashimoto, Isaya ^a   Igarashi, Yoshiko ^a   Tsuneyama, Koichi ^a   Tsukada, Kazuhiro ^a   Irimura, Tatsuro ^b   Shibahara, Naotoshi ^a   Takasaki, Ichiro ^a   Inujima, Akiko ^a   Nakayama, Takashi ^c   Yoshie, Osamu ^d   Sakurai, Hiroaki ^e   Saiki, Ikuo ^a   Koizumi, Keiichi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c KINKI UNIVERSITY   (Japan)

^d KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Apoptosis; Colorectal liver metastasis; CXCL16; IRF8; TNF

Indexed keywords

CASPASE 3; CXCL16 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA; ALPHA CHEMOKINE; CXCL16 PROTEIN, HUMAN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR; SCAVENGER RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; GENE; GENE SILENCING; IMMUNOSURVEILLANCE; INTRACELLULAR SIGNALING; IRF8 GENE; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; ANIMAL; CELL MEMBRANE; COLORECTAL TUMOR; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; LIVER TUMOR; MACROPHAGE; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SECONDARY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL MEMBRANE; CHEMOKINES, CXC; COLORECTAL NEOPLASMS; DRUG RESISTANCE; GENE EXPRESSION; GENE SILENCING; INTERFERON REGULATORY FACTORS; LIVER NEOPLASMS; MACROPHAGES; MICE; RECEPTORS, SCAVENGER; RNA INTERFERENCE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84924671028     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-949     Document Type: Article

References (45)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107.
2. Penna C, Nordlinger B: Surgery of liver metastases from colorectal cancer: new promises. Br Med Bull 2002, 64:127-140. 10.1093/bmb/64.1.127.
3. Roth JA, Cristiano RJ: Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst 1997, 89:21-39. 10.1093/jnci/89.1.21.
4. Homey B, Müller A, Zlotnik A: Chemokines: agents for the immunotherapy of cancer? Nat Rev Immunol 2002, 2:175-184. 10.1038/nri748.
5. Koizumi K, Hojo S, Akashi T, Yasumoto K, Saiki I: Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci 2007, 98:1652-1658. 10.1111/j.1349-7006.2007.00606.x.
6. Matloubian M, David A, Engel S, Ryan JE, Cyster JG: A transmembrane CXC chemokine is a ligand for HIV coreceptor Bonzo. Nat Immunol 2000, 1:298-304. 10.1038/79738.
7. Shimaoka T, Kume N, Minami M: Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chem 2000, 275:40663-40666. 10.1074/jbc. C000761200.
8. Wilbanks A, Zondlo SC, Murphy K, Mak S, Soler D, Langdon P, Andrew DP, Wu L, Briskin M: Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines. J Immunol 2001, 166:5145-5154. 10.4049/jimmunol.166.8.5145.
9. Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, Broadway N, Hartmann D, Sedlacek R, Dietrich S, Muetze B, Schuster B, Kallen KJ, Saftig P, Rose-John S, Ludwig A: The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol 2004, 172:6362-6372. 10.4049/jimmunol.172.10.6362.
10. Gough PJ, Garton KJ, Wille PT, Rychlewski M, Dempsey PJ, Raines EW: A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J Immunol 2004, 172:3678-3685. 10.4049/jimmunol.172.6.3678.
11. Ludwig A, Hundhausen C, Lambert MH, Broadway N, Andrews RC, Bickett DM, Leesnitzer MA, Becherer JD: Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Comb Chem High Throughput Screen 2005, 8:161-171. 10.2174/1386207053258488.
12. Kim CH, Kunkel EJ, Boisvert J, Johnston B, Campbell JJ, Genovese MC, Greenberg HB, Butcher EC: Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest 2001, 107:595-601. 10.1172/JCI11902.
13. Kim CH, Johnston B, Butcher EC: Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. Blood 2002, 100:11-16. 10.1182/blood-2001-12-0196.
14. Zlotnik A, Burkhardt AM, Homey B: Homeostatic chemokine receptors and organ-specific metastasis. Nat Rev Immunol 2011, 11:597-606. 10.1038/nri3049.
15. Hojo S, Koizumi K, Tsuneyama K, Arita Y, Cui Z, Shinohara K, Minami T, Hashimoto I, Nakayama T, Sakurai H, Takano Y, Yoshie O, Tsukada K, Saiki I: High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer. Cancer Res 2007, 67:4725-4731. 10.1158/0008-5472.CAN-06-3424.
16. Gutwein P, Schramme A, Sinke N, Abdel-Bakky MS, Voss B, Obermüller N, Doberstein K, Koziolek M, Fritzsche F, Johannsen M, Jung K, Schaider H, Altevogt P, Ludwig A, Pfeilschifter J, Kristiansen G: Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients. Eur J Cancer 2009, 45:478-489. 10.1016/j.ejca.2008.10.023.
17. Lu Y, Wang J, Xu Y, Koch AE, Cai Z, Chen X, Galson DL, Taichman RS, Zhang J: CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro. Mol Cancer Res 2008, 6:546-554. 10.1158/1541-7786.MCR-07-0277.
18. Darash-Yahana M, Gillespie JW, Hewitt SM, Chen YY, Maeda S, Stein I, Singh SP, Bedolla RB, Peled A, Troyer DA, Pikarsky E, Karin M, Farber JM: The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers. PLoS One 2009, 4:e6695. 10.1371/journal.pone.0006695.
19. Wågsäter D, Hugander A, Dimberg J: Expression of CXCL16 in human rectal cancer. Int J Mol Med 2004, 14:65-69.
20. Wente MN, Gaida MM, Mayer C, Michalski CW, Haag N, Giese T, Felix K, Bergmann F, Giese NA, Friess H: Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma. Int J Oncol 2008, 33:297-308.
21. Ou DL, Chen CL, Lin SB, Hsu CH, Lin LI: Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy. J Pathol 2006, 210:363-373. 10.1002/path.2053.
22. Held-Feindt J, Rehmke B, Mentlein R, Hattermann K, Knerlich F, Hugo HH, Ludwig A, Mehdorn HM: Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas. Glia 2008, 56:764-774. 10.1002/glia.20651.
23. Seidl H, Richtig E, Tilz H, Stefan M, Schmidbauer U, Asslaber M, Zatloukal K, Herlyn M, Schaider H: Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma. Hum Pathol 2007, 38:768-780. 10.1016/j.humpath.2006.11.013.
24. Zhou Q, Peng RQ, Wu XJ, Xia Q, Hou JH, Ding Y, Zhou QM, Zhang X, Pang ZZ, Wan DS, Zeng YX, Zhang XS: The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer. J Transl Med 2010, 8:13. 10.1186/1479-5876-8-13.
25. Gordon S: Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35. 10.1038/nri978.
26. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M: The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686. 10.1016/j.it.2004.09.015.
27. van der Bij GJ, Bögels M, Oosterling SJ, Kroon J, Schuckmann DT, de Vries HE, Meijer S, Beelen RH, van Egmond M: Tumor infiltrating macrophages reduce development of peritoneal colorectal carcinoma metastases. Cancer Lett 2008, 262:77-86. 10.1016/j.canlet.2007.11.040.
28. Ong SM, Tan YC, Beretta O, Jiang D, Yeap WH, Tai JJ, Wong WC, Yang H, Schwarz H, Lim KH, Koh PK, Ling KL, Wong SC: Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response. Eur J Immunol 2012, 42:89-100. 10.1002/eji.201141825.
29. Paschos KA, Majeed AW, Bird NC: Role of Kupffer cells in the outgrowth of colorectal cancer liver metastases. Hepatol Res 2010, 40:83-94. 10.1111/j.1872-034X.2009.00578.x.
30. Sturm JW, Magdeburg R, Berger K, Petruch B, Samel S, Bönninghoff R, Keese M, Hafner M, Post S: Influence of TNFA on the formation of liver metastases in a syngenic mouse model. Int J Cancer 2003, 107:11-21. 10.1002/ijc.11320.
31. Kelker HC, Oppenheim JD, Stone-Wolff D, Henriksen-DeStefano D, Aggarwal BB, Stevenson HC, Vilcek J: Characterization of human tumor necrosis factor produced by peripheral blood monocytes and its separation from lymphotoxin. Int J Cancer 1985, 36:69-73. 10.1002/ijc.2910360112.
32. Wajant H, Pfizenmaier K, Scheurich P: Tumor necrosis factor signaling. Cell Death Differ 2003, 10:45-65. 10.1038/sj.cdd.4401189.
33. Driggers PH, Ennist DL, Gleason SL, Mak WH, Marks MS, Levi BZ, Flanagan JR, Appella E, Ozato K: An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci U S A 1990, 87:3743-3747. 10.1073/pnas.87.10.3743.
34. Tamura T, Ozato K: ICSBP/IRF-8: its regulatory roles in the development of myeloid cells. J Interferon Cytokine Res 2002, 22:145-152. 10.1089/107999002753452755.
35. Yang D, Thangaraju M, Browning DD, Dong Z, Korchin B, Lev DC, Ganapathy V, Liu K: IFN regulatory factor 8 mediates apoptosis in nonhemopoietic tumor cells via regulation of Fas expression. J Immunol 2007, 179:4775-4782. 10.4049/jimmunol.179.7.4775.
36. Yang D, Wang S, Brooks C, Dong Z, Schoenlein PV, Kumar V, Ouyang X, Xiong H, Lahat G, Hayes-Jordan A, Lazar A, Pollock R, Lev D, Liu K: IFN regulatory factor 8 sensitizes soft tissue sarcoma cells to death receptor-initiated apoptosis via repression of FLICE-like protein expression. Cancer Res 2009, 69:1080-1088.
37. Liu K, Abrams SI: Coordinate regulation of IFN consensus sequence-binding protein and caspase-1 in the sensitization of human colon carcinoma cells to Fas-mediated apoptosis by IFN-gamma. J Immunol 2003, 170:6329-6337. 10.4049/jimmunol.170.12.6329.
38. Yang D, Thangaraju M, Greeneltch K, Browning DD, Schoenlein PV, Tamura T, Ozato K, Ganapathy V, Abrams SI, Liu K: Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic phenotype in metastatic tumor cells. Cancer Res 2007, 67:3301-3309. 10.1158/0008-5472.CAN-06-4068.
39. Saito T, Yamaguchi J: 2-Chloroadenosine: a selective lethal effect to mouse macrophages and its mechanism. J Immunol 1985, 134:1815-1822.
40. van Horssen R, Ten Hagen TL, Eggermont AM: TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist 2006, 11:397-408. 10.1634/theoncologist.11-4-397.
41. Burchert A, Cai D, Hofbauer LC, Samuelsson MK, Slater EP, Duyster J, Ritter M, Hochhaus A, Müller R, Eilers M, Schmidt M, Neubauer A: Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2. Blood 2004, 103:3480-3489. 10.1182/blood-2003-08-2970.
42. Gabriele L, Phung J, Fukumoto J, Segal D, Wang IM, Giannakakou P, Giese NA, Ozato K, Morse HC 3rd: Regulation of apoptosis in myeloid cells by interferon consensus sequence-binding protein. J Exp Med 1999, 190:411-421. 10.1084/jem.190.3.411.
43. Zhang L, Ran L, Garcia GE, Wang XH, Han S, Du J, Mitch WE: Chemokine CXCL16 regulates neutrophil and macrophage infiltration into injured muscle, promoting muscle regeneration. Am J Pathol 2009, 175:2518-2527. 10.2353/ajpath.2009.090275.
44. Kee JY, Ito A, Hojo S, Hashimoto I, Igarashi Y, Tsukada K, Irimura T, Shibahara N, Nakayama T, Yoshie O, Sakurai H, Saiki I, Koizumi K: Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model. Oncol Rep 2013, 29:975-982.
45. Ohmura K, Ishimori N, Ohmura Y, Tokuhara S, Nozawa A, Horii S, Andoh Y, Fujii S, Iwabuchi K, Onoé K, Tsutsui H: Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice. Arterioscler Thromb Vasc Biol 2010, 30:193-199. 10.1161/ATVBAHA.109.198614.